National Tuberculosis and Leprosy Control Program
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
BMJ,Dodd PJ, et al. Thorax 2017;72:559–575. doi:10.1136/thoraxjnl-2016-209421
Zoonotic tuberculosis (TB) is a form of TB in people predominantly caused by the bacterial species, Mycobacterium bovis, which belongs to the M. tuberculosis complex. The implications of zoonotic TB go beyond human health. The organism is host-adapted to cattle, where it is refer...red to as bovine TB, and it also causes TB in other animal species including wildlife. Bovine TB has an important economic impact and threatenslivelihoods.
more
The goal of the United States Government for the President's Emergency Plan for AIDS Relief (PEPFAR) in Mozambique is to support country efforts to achieve epidemic control by 2020 through evidence-based policies and interventions to drive progress and save
lives. This document details PEPFAR's op...erational plan in Mozambique.
more
These guidelines aim to guide all health care providers in Myanmar, accommodating the situation of different settings in the context of progressive decentralization of HIV services. Notable changes from the previous edition include:
• diagnosis of HIV
• update on the initiation of ART<...br>
• new ARV drugs and regimens
• new recommendation on infant prophylaxis
• PrEP and PEP updates
• updates on co-infections and comorbidities management
It should be noted that these guidelines are meant for the operational level and are adapted and adopted in line with existing Myanmar context.
more
Meeting Report
Bangkok, Thailand 8-11 August 2016
Updated May 2017
This document is meant to respond to the questions:
■ What health interventions should the child receive and when should s/he receive it?
■ What health behaviours should a mother/caregiver practise (or not practise)?
The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing of initiation of antiretroviral therapy (ART) for all people living with HIV.
WHO recommends that a... package of screening, prophylaxis, rapid ART initiation and intensified adherence interventions be offered to everyone living with HIV presenting with advanced disease.
WHO strongly recommends that rapid ART initiation should be offered to people living with HIV following confirmed diagnosis and clinical assessment. Rapid initiation of ART is defined as within seven days of HIV diagnosis. WHO further strongly recommends ART initiation on the same day as HIV diagnosis based on the person’s willingness and readiness to start ART immediately, unless there are clinical reasons to delay treatment.
more
The evidence base for differentiated care for stable patients has grown in recent years. There has been less attention, however, to developing differentiated models of care for patients with advanced or unstable HIV disease. Current clinical guidelines and policies regarding optimal packages of care... for high-risk patients give few or no recommendations about how, by whom, or where they should be delivered for optimal impact.
more
La quatrième édition des Lignes directrices de l'OMS pour la qualité de l'eau potable s'appuie sur plus de 50 ans d'orientations sur la qualité de l'eau potable qui font autorité en matière de mesures de santé publique lorsqu’il s’agit de mettre en place des réglementations et des normes... nationales pour garantir la sécurité de l'eau.
Ces lignes directrices s’adressent principalement aux responsables de la réglementation dans le domaine de l’eau et de la santé, aux décideurs et à leurs conseillers, et ont pour objectif d’aider lors de la mise au point de normes nationales. Elles sont aussi utilisées, ainsi que les documents associés, par comme source d’informations sur la qualité et l’hygiène de l’eau et sur les stratégies de gestion efficaces.
more
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s...ix countries of the SEA Region. MDR-TB could potentially replace drug-susceptible TB, and constitutes a threat to global public health security. The South- East Asia Regional Response Framework for DR-TB 2017–2021 complements the Ending TB in the South-East Asia Region: Regional Strategic Plan 2016–2020” and outlines key strategies for reducing morbidity, mortality and transmission of DR-TB.
more
Ces lignes directrices prônent une approche centrée sur la personne des informations stratégiques sur le VIH, ce qui implique de cesser de collecter des données agrégées dans les services (par exemple, le nombre de tests de dépistage du VIH administrés) pour s’intéresser au patient qui re...çoit une cascade de services liés entre eux, afin d’améliorer les soins prodigués aux patients et les résultats sanitaires.
Elles réunissent les orientations données en matière de systèmes de suivi des patients et de cas d’infection à VIH dans le cadre du système de surveillance de santé publique. Elles recommandent le recours à un identifiant unique pour le patient, afin d'établir une liaison entre tous les services de santé, ce qui permet de mesurer la cascade de services sur la durée.
more
A survey of prevention, testing and treatment policies and practices